Radiosurgery for Essential Tremor
Recruiting in Palo Alto (17 mi)
Overseen byMarkus Bredel, MD, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Alabama at Birmingham
No Placebo Group
Trial Summary
What is the purpose of this trial?This trial is testing a non-surgical radiation treatment to help people with severe tremors from Essential Tremor or Parkinson's Disease who can't have traditional brain surgery. The treatment aims to reduce shaking by targeting specific brain areas with precise radiation. This minimally invasive alternative to traditional brain surgery is designed for treating tremors in conditions like Essential Tremor and Parkinson's Disease.
Eligibility Criteria
This trial is for adults with severe, treatment-resistant shaking (tremor) due to Essential Tremor or Parkinson's Disease who can't have deep brain stimulation because of health issues or personal choice. They should be able to perform daily activities with minimal assistance (ECOG status 0-2).Inclusion Criteria
All patients must be given written informed consent.
I am 18 years old or older.
I am able to care for myself and up and about more than 50% of my waking hours.
+1 more
Exclusion Criteria
You cannot have an MRI because of a medical reason, such as having a pacemaker.
I have had brain radiation therapy before.
Participant Groups
The study tests a non-invasive procedure called Virtual Cone Radiosurgical Thalamotomy, which targets the brain area causing tremors. It aims to reduce tremors in patients who haven't improved with medication and aren't suitable for surgery.
1Treatment groups
Experimental Treatment
Group I: 130 Gy Radiation & Unframed Virtual ConeExperimental Treatment1 Intervention
130 Gy Virtual Cone Radiosurgery Unframed (Face Mask)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology CenterBirmingham, AL
Loading ...
Who Is Running the Clinical Trial?
University of Alabama at BirminghamLead Sponsor